Advanced Oxygen Therapy Inc. v. Orthoserve Inc.

CourtDistrict Court, S.D. New York
DecidedNovember 17, 2021
Docket1:21-cv-02089
StatusUnknown

This text of Advanced Oxygen Therapy Inc. v. Orthoserve Inc. (Advanced Oxygen Therapy Inc. v. Orthoserve Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Advanced Oxygen Therapy Inc. v. Orthoserve Inc., (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ADVANCED OXYGEN THERAPY INC., Plaintiff, – against – OPINION & ORDER 21 Civ. 2089 (ER) ORTHOSERVE INC., ANGELA BABAKHANOV, DANIL BABAKHANOV, and J ONATHAN BABAKHANOV, Defendants.

Ramos, D.J.: Advanced Oxygen Therapy, Inc. brought this action against Orthoserve, Inc., Angela Babakhanov, Danil Babakhanov, and Jonathan Babakhanov (collectively, “Defendants”), alleging breach of contract, breach of the implied covenant of good faith and fair dealing, breach of fiduciary duty, conversion, and unjust enrichment. Defendants now move to dismiss all but the claim for breach of contract. For the reasons set forth below, the motion is GRANTED in part and DENIED in part. I. BACKGROUND a. Factual Background Advanced Oxygen is a medical device and technology company which provides in-home treatments of its patented Topical Wound Oxygen (“TWO2”) therapy to patients suffering from severe and chronic wounds such as burn wounds and pressure ulcers. Doc. 1 ¶ 20-21. Advanced Oxygen is incorporated in Nevada, with its principal place of business in California. Id. ¶ 10. In August 2017, Advanced Oxygen opened a New York City office to support its growth in the region. Id. ¶ 23. At the time, Advanced Oxygen had not yet received the necessary regulatory authorization to provide its services and sell its durable medical equipment (“DME”) directly to patients in New York, so it contracted with Orthoserve to act as an intermediary. Id. ¶¶ 3, 24. Orthoserve is an authorized New York DME supplier, and is incorporated in New York, with its principal place of business in the Bronx, New York. Id. ¶¶ 3, 11. Danil Babakhanov is the president of Orthoserve, Angela Babakhanov is the general manager of Orthoserve, and Jonathan Babakhanov is an Orthoserve executive. Id. ¶¶ 12-14.

In approximately September 2017, Advanced Oxygen and Orthoserve entered into a contract whereby they agreed that Orthoserve would purchase and re-sell Advanced Oxygen’s products and services to New York Medicaid Managed Care customers and insurers. Id. ¶ 25-26. Orthoserve was to act as an intermediary and coordinate with the Medicaid Managed Care insurers through billing intermediary Integra Partners to process insurance claims and collect payments. Id. ¶ 28. Orthoserve would receive the insurance claim payments, retain 15% of such payments, and forward the remaining 85% to Advanced Oxygen on a weekly basis. Id. ¶ 25-26. The contract also provided that in instances where the insurance companies would pay Orthoserve amounts that exceeded the contract rates, the insurers would correct this by recouping

from Orthoserve the full amount already paid and then repaying the correct amount. Id. ¶ 29. Orthoserve would wait to pay the 85% owed to Advanced Oxygen until after this recoupment and reconciliation process was completed by the insurers. Id. ¶ 31. On October 24, 2018, Jonathan Babakhanov emailed Advanced Oxygen’s director of operations for New York, and notified him that they would be holding $250,000 of fully reconciled claim payments owed to Advanced Oxygen in escrow in order to protect the company in the event of future recoupments. Id. ¶ 32-33. Angela Babakhanov consented to the email being sent and was copied on the email. Id. ¶ 33. Following a phone conversation between Advanced Oxygen’s chief executive officer and Jonathan and Angela Babakhanov, the CEO emailed Angela and Jonathan on November 5, 2018 to memorialize their escrow agreement. Id. ¶ 34. The agreement detailed that Orthoserve would hold back payments to Advanced Oxygen in order to build up a temporary escrow of $250,000, the purpose of which was to mitigate potential risk to Orthoserve related to overpaid claims. Id. Per the agreement, once the $250,000 was established, Orthoserve would return to making all further claim payments to Advanced

Oxygen weekly as established by the parties’ prior agreement. Id. The agreement made explicit that it was “not the intention of Orthoserve to retain any funds, or delay paying any monies” due to Advanced Oxygen once the overpayments were reconciled by the insurer. Id. Pursuant to the escrow agreement, Defendants established a $250,000 escrow by withholding the following payments due to Advanced Oxygen from insurer Healthfirst: a. Payment due the week of October 8, 2018, totaling $53,570.40. b. Payment due the week of October 15, 2018, totaling $36,427.88. c. Payment due the week of October 22, 2018, totaling $50,460.56. d. Payment due the week of October 29, 2018, totaling $26,788.91.

e. Payment due the week of November 5, 2018, totaling $64,371.42. f. Payment due the week of November 13, 2018, totaling $13,781.83. g. Payment due the week of November 19, 2018, totaling $4,599.00. Id. ¶ 35. As of September 22, 2020, all of the claims that produced the payments making up the $250,000 escrow have been fully reconciled by the insurance company and are therefore owed to Advanced Oxygen per the parties’ agreements. Id. ¶ 37-38. Advanced Oxygen alleges that Orthoserve has refused to deliver these payments, as well as fully reconciled amounts from additional Healthfirst insurance claims dating back to 2017 and 2018, totaling an additional $360,073.90. Id. ¶ 39-40. In approximately September and October 2020, Advanced Oxygen repeatedly sent the United Parcel Service to Orthoserve to collect these additional payments and Orthoserve failed to make the payments. Id. ¶ 42. Advanced Oxygen further alleges that Orthoserve is withholding its portion of claim payments from other insurers, including but not limited to Fidelis Care and WellCare, and Orthoserve has refused to say whether these claims have been reconciled and are therefore due to Advanced Oxygen, constituting a breach of the

parties’ original agreement. Id. ¶44-46. Advanced Oxygen seeks damages “in no event less than $610,073.90, plus prejudgment and post-judgment interest.” Id. at 13. b. Procedural Background On March 10, 2021, Advanced Oxygen filed the instant complaint, asserting claims for breach of contract, breach of the implied covenant of good faith and fair dealing, and unjust enrichment against Orthoserve, and asserting claims for breach of fiduciary duty and conversion against all defendants. Doc. 1. On May 26, 2021, Defendants moved to dismiss all claims asserted by Advanced Oxygen, save for the breach of contract claim. Doc. 26. II. LEGAL STANDARD

“To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). A claim is facially plausible “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. (citing Twombly, 550 U.S. at 556). The plaintiff must allege sufficient facts to show “more than a sheer possibility that a defendant has acted unlawfully.” Id. (citing Twombly, 550 U.S. at 556). However, this “flexible ‘plausibility standard’” is not a heightened pleading standard, In re Elevator Antitrust Litig., 502 F.3d 47, 50 n.3 (2d Cir. 2007) (quotation marks and citation omitted), and “a complaint…does not need detailed factual allegations” to survive a motion to dismiss, Twombly, 550 U.S. at 555. The question on a motion to dismiss “is not whether a plaintiff will ultimately prevail but whether the claimant is entitled to offer evidence to support the claims.” Sikhs for Justice v. Nath, 893 F. Supp. 2d 598, 615 (S.D.N.Y. 2012) (quoting Villager Pond, Inc. v. Town of Darien,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Halebian v. Berv
644 F.3d 122 (Second Circuit, 2011)
Thyroff v. Nationwide Mutual Insurance Company
460 F.3d 400 (Second Circuit, 2006)
In Re Elevator Antitrust Litigation
502 F.3d 47 (Second Circuit, 2007)
ESI, Inc. v. Coastal Power Production Co.
995 F. Supp. 419 (S.D. New York, 1998)
Colavito v. New York Organ Donor Network, Inc.
860 N.E.2d 713 (New York Court of Appeals, 2006)
Geler v. National Westminster Bank USA
770 F. Supp. 210 (S.D. New York, 1991)
AMUSEMENT INDUSTRY, INC. v. Stern
786 F. Supp. 2d 758 (S.D. New York, 2011)
High View Fund, L.P. v. Hall
27 F. Supp. 2d 420 (S.D. New York, 1998)
Citadel Management, Inc. v. Telesis Trust, Inc.
123 F. Supp. 2d 133 (S.D. New York, 2000)
Moses v. Martin
360 F. Supp. 2d 533 (S.D. New York, 2004)
Sommer v. Federal Signal Corp.
79 N.Y.2d 540 (New York Court of Appeals, 1992)
Kurtzman v. Bergstol
40 A.D.3d 588 (Appellate Division of the Supreme Court of New York, 2007)
Amcan Holdings, Inc. v. Canadian Imperial Bank of Commerce
70 A.D.3d 423 (Appellate Division of the Supreme Court of New York, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Advanced Oxygen Therapy Inc. v. Orthoserve Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/advanced-oxygen-therapy-inc-v-orthoserve-inc-nysd-2021.